| c-Myc | Cellular myelocytomatosis oncogene |
| Caco-2 | Colon carcinoma cell line 2 |
| DAPI | 4′,6-Diamidino-2-Phenylindole, Dihydrochloride |
| EdU | 5-ethynyl-2′-deoxyuridine |
| EPDENs | exosome-like nanoparticles |
| FBS | fetal bovine serum |
| GSK-3β | glycogen synthase kinase-3β |
| i-NC | inhibitor normal control |
| IPEC-J2 | porcine jejunum epithelial cell line |
| LEF | lymphoid enhancing factor |
| MTT | 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide |
| NC | normal control |
| PCNA | proliferating cell nuclear antigen |
| PMSF | phenylmethylsulphonyl fluoride |
| STC-1 | Invasive small intestinal neuroendocrine carcinoma 1 |
| TCF | T cell factor |
| UTR | untranslated region |
| Wnt | Wingless Int1 |